Diligence memo · auto-generated · as of July 2, 2026
Nanomedical Diagnostics, Inc.
Nanomedical Diagnostics, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Nanomedical Diagnostics, Inc. operates in Medical Devices, based in SAN DIEGO.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Nanomedical Diagnostics, Inc. has raised $12M in disclosed capital across 7 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $7.4M on 2019-03-27.
Most recent recorded round closed around 2020-09-11.
Valuation (modeled)modeled
Provath models Nanomedical Diagnostics, Inc. at approximately $38M (range $2.1M–$197M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.77× the median modeled value of Series A Medical Devices companies in 2019–2021 (17 peers) — value vs value, same stage and era. Within the normal band (77% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 12 months.
Last raise 5.8 yr ago; this sector typically re-raises about every 16 months.
Silent for over 3× the sector's normal cadence.
The last round was 4.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 81% of Medical Devices peers (233 compared).
Modeled value ranks above 73% of those peers.
Closest niche peers: Reliant Immune Diagnostics, Inc., Pristine Surgical LLC, Predictive Health Diagnostics Co., Juno Diagnostics, Inc., Allotrope Medical Inc..
Peoplefiled
9 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.